Status: Not yet recruiting
Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy Volunteers
A randomized, open-label, multiple-dose, crossover phase 1 clinical trial to compare and evaluate the safety, pharmacokinetics and pharmacodynamics characteristics after oral administration of UI059 and UIC202201 in healthy adult volunteers
Participants needed: 60
Trial details
Phase: Phase 1Age: 19+Biological sex: AllType: InterventionalSponsor: Korea United Pharm. Inc.Updated: Jul 27, 2026Locations: 1
Eligibility criteria
Healthy adult volunteers aged 19 years or older at the time of screening. [+6]
Current or past history of clinically significant liver, kidney, neurological, p... [+24]